公司概覽
業務類別 --
業務概覽 Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
公司地址 Muenchensteinerstrasse 38, Basel, CHE, CH-4002
電話號碼 +41 613168111
傳真號碼 +41 613169111
公司網頁 https://www.lonza.com
員工數量 16866
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
Mr. Christoph Mader Lead Independent Director 01/04/2026
Mr. Eric Drape Independent Director 01/04/2026
Mr. David W. Meline Independent Director 01/04/2026
Ms. Angelica Kohlmann Independent Director 01/04/2026
Mr. Juan Andres Independent Director 01/04/2026
Dr. Marion Helmes, PhD Independent Director 01/04/2026
Mr. Jean-Marc Huet Chairman of the Board 01/04/2026
 
所屬ETF (更新日期: 09/05/2026 02:56)
代號 名稱 佔比% 持有日期
APIEActivePassive International Equity ETF0.001%30/04/2026
SPWOSP Funds S&P World ETF0.001%30/04/2026
AVTMAvantis Total Equity Markets ETF<0.000001%14/03/2026
ENDWCambria Endowment Style ETF<0.000001%26/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.